Vor Biopharma VOR Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's deferred tax assets and other non-current assets?
- Vor Biopharma (VOR) reported deferred tax assets and other non-current assets of $2.41M in Q1 2026.
- How has Vor Biopharma's deferred tax assets and other non-current assets changed year-over-year?
- Vor Biopharma's deferred tax assets and other non-current assets increased by 1.6% year-over-year, from $2.37M to $2.41M.
- What is the long-term trend for Vor Biopharma's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Vor Biopharma's deferred tax assets and other non-current assets has grown at a -6.8% compound annual growth rate (CAGR), from $3.4M to $2.38M.